SIRT6 and neoplasm: Tumor volumes at endpoint for negative control and SIRT6-depleted tumors were 426.7 ± 60.9 mm3, 214.7 ± 33.3 mm3 and 240.5 ± 42.6 mm3, respectively (Fig 2A).